Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Abnormal interleukin-7 function in common variable immunodeficiency.

Are Martin Holm1, Pål Aukrust, Jan Kristian Damås

  • 1Section of Clinical Immunology and Infectious Diseases, Medical Center, Oslo, Norway. a.m.holm@klinmed.uio.no

Blood
|December 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulated Proteins in Plasma Distinguishing Loeys-Dietz Syndrome from Other Heritable Thoracic Aortic Disease - An Explorative Study.

Scandinavian cardiovascular journal : SCJ·2026
Same author

In-depth analysis of sampling practice and yield of blood cultures.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

How fair is the Composite Allocation Score for lung transplantation?

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Long-term trends in incidence and mortality in Staphylococcus aureus bacteraemia; a retrospective population-based study from Central Norway 1996-2022.

BMC infectious diseases·2026
Same author

Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.

Nature microbiology·2026

Common variable immunodeficiency (CVID) involves low immunoglobulin levels and frequent infections. This study found elevated Interleukin-7 (IL-7) in some CVID patients, suggesting new insights into disease mechanisms.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinemia, leading to recurrent infections.
  • T-cell abnormalities are frequently observed in CVID patients.
  • Interleukin-7 (IL-7) plays a crucial role in lymphocyte homeostasis and has been implicated in lymphopenic conditions.

Purpose of the Study:

  • To investigate the role of Interleukin-7 (IL-7) in a subgroup of patients with Common variable immunodeficiency (CVID).
  • To explore potential novel pathogenic mechanisms and identify therapeutic targets in CVID.

Main Methods:

  • Measurement of plasma Interleukin-7 (IL-7) levels in CVID patients.
  • Analysis of circulating T-cell populations, including CD8+ T cells, apoptosis rates, and effector-memory T cell subsets (CCR7-).

Related Experiment Videos

  • In vitro assessment of T-cell response to IL-7, including proliferation and cytokine secretion (interferon gamma, transforming growth factor beta).

    • Main Results:

    • Elevated plasma levels of circulating Interleukin-7 (IL-7) were identified in a subgroup of CVID patients.
    • These patients exhibited increased numbers of circulating CD8+ T cells with reduced apoptosis.
    • A predominance of CC chemokine receptor 7- (CCR7-) effector-memory T cells and impaired in vitro response to IL-7 were observed in some patients.

    Conclusions:

    • Elevated IL-7 levels and specific T-cell abnormalities characterize a subset of CVID patients.
    • These findings suggest novel pathogenic pathways contributing to CVID.
    • The study highlights IL-7 and associated T-cell dysregulation as potential targets for future CVID research and therapeutic strategies.